Diabetes is an increasingly prevalent disease, currently affecting more than 500 million adults worldwide. There is still no cure for type 1 or type 2 diabetes,...
A 24-week trial showed up to a 52% reduction in urine protein and a 30% reduction in kidney inflammation among participants. study: Semaglutide in patients with...
Researchers from Massachusetts General Brigham and colleagues found that the use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023, and surgery...
Semaglutide is associated with a 40-70% lower risk of being diagnosed with Alzheimer's disease for the first time. Type 2 diabetic patients compared to other diabetes...
Semaglutide— diabetes and weight loss Drugs known by trade names such as Ozempic and Wegs— continues to show promise in treating a variety of other conditions....
Steve Crist – Corbis | Corbis News | Getty Images novo nordiskblockbuster diabetes drug Ozempic May reduce the risk of developing the disease alzheimer's diseaseThe results...
Recent Comments